Skip to main content
. 2024 Aug 17;16(8):e67062. doi: 10.7759/cureus.67062

Table 5. Association of rifampicin sensitivity with the independent variables of the study participants (n=141).

TB: Tuberculosis

Variables Rif S (n=135) Rif R (n=6) P value
Frequency (%)
Gender
Male (n=99) 95 (70.4) 4 (66.7) 0.846
Female (n=42) 40 (29.6) 2 (33.3)
Age group
60 years or less (n=119) 114 (84.4) 5 (83.3) 0.941
>60 years (n=22) 21 (15.6) 1 (16.7)
Body Mass Index (kg/m2)
<18.5 (n=53) 50 (37.0) 3 (50.0) 0.521
18.5 or more (n=88) 85 (63.0) 3 (50.0)
Residence
Urban (n=89) 86 (63.7) 3 (50.0) 0.496
Rural (n=52) 49 (36.3) 3 (50.0)
Comorbidity
Present (n=48) 56 (41.5) 2 (33.3) 0.794
Absent (n=93) 89 (65.9) 4 (66.7)
Addiction history
Addiction (n=79) 76 (56.3) 3 (50.0) 0.761
No addiction (n=62) 59 (43.7) 3 (50.0)
Socioeconomic class
Low (n=110) 106 (78.5) 4 (66.7) 0.636
Middle (n=27) 25 (18.5) 2 (33.3)
High (n=4) 4 (3.0) 0 (0.0)
Previous history of Pulmonary TB
New (n=92) 89 (65.9) 3 (50.0) 0.422
Previously treated (n=49) 46 (34.1) 3 (50.0)
Family contact exposure
Drug Sensitive TB (n=16) 15 (11.1) 1 (16.7) 0.004
Drug Resistant TB (n=2) 1 (0.7) 1 (16.7)
Absent (n=123) 119 (88.1) 4 (66.7)
Chest X Ray lesion
Cavitary (n=121) 115 (85.2) 6 (100.0) 0.308
Non cavitary (n=20) 20 (14.8) 0 (0.0)
Chest X Ray lesion extent
Limited (n=48) 48 (35.6) 0 (0.0) 0.072
Extensive (n=93) 87 (64.4) 6 (100.0)